Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Regains Nasdaq Compliance

NEW YORK (GenomeWeb News) – Response Genetics today said that it has regained compliance with the Nasdaq Capital Market's rule covering the minimum market value of listed securities.

The Los Angeles-based molecular diagnostics developer said that it was notified by Nasdaq on Feb. 16 that it had regained compliance and the "delisting matter is now closed."

Earlier this month, the firm raised more than $7.8 million from a private placement of roughly 5.3 million shares of common stock at $1.50 per share.

In early Tuesday trade, shares of Response Genetics rose 3 percent to $2.17.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.